{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:05:14Z","timestamp":1781021114595,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004896","name":"Eisai Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023368","name":"Eisai Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine: X"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.sleepx.2026.100188","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:42:06Z","timestamp":1777074126000},"page":"100188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of lemborexant on insomnia severity, morning alertness, and cognition in participants with insomnia disorder and mild obstructive sleep apnea"],"prefix":"10.1016","volume":"11","author":[{"given":"Raymond","family":"Gottschalk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn Y.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0807-2167","authenticated-orcid":false,"given":"Margaret","family":"Moline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5 suppl","key":"10.1016\/j.sleepx.2026.100188_bib1","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.5664\/jcsm.26929","article-title":"Insomnia: definition, prevalence, etiology, and consequences","volume":"3","author":"Roth","year":"2007","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"10.1016\/j.sleepx.2026.100188_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"10.1016\/j.sleepx.2026.100188_bib3","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.chest.2020.12.002","article-title":"Sleep apnea and insomnia: emerging evidence for effective clinical management","volume":"159","author":"Ong","year":"2021","journal-title":"Chest"},{"issue":"17","key":"10.1016\/j.sleepx.2026.100188_bib4","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.3390\/ijerph18179248","article-title":"Comorbid insomnia and obstructive sleep apnea (COMISA): current concepts of patient management","volume":"18","author":"Ragnoli","year":"2021","journal-title":"Int J Environ Res Publ Health"},{"issue":"12","key":"10.1016\/j.sleepx.2026.100188_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/brainsci9120371","article-title":"Co-morbid insomnia and sleep apnea (COMISA): prevalence, consequences, methodological considerations, and recent randomized controlled trials","volume":"9","author":"Sweetman","year":"2019","journal-title":"Brain Sci"},{"issue":"3","key":"10.1016\/j.sleepx.2026.100188_bib6","first-page":"487","article-title":"Gender issues in obstructive sleep apnea","volume":"94","author":"Geer","year":"2021","journal-title":"Yale J Biol Med"},{"issue":"1","key":"10.1016\/j.sleepx.2026.100188_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsmc.2017.09.002","article-title":"Insomnia in the older adult","volume":"13","author":"Brewster","year":"2018","journal-title":"Sleep Med Clin"},{"issue":"1","key":"10.1016\/j.sleepx.2026.100188_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01958-2021","article-title":"Comorbid insomnia and sleep apnoea is associated with all-cause mortality","volume":"60","author":"Lechat","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.sleepx.2026.100188_bib9","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2147\/NSS.S379252","article-title":"All-cause mortality in people with co-occurring insomnia symptoms and sleep apnea: analysis of the Wisconsin Sleep Cohort","volume":"14","author":"Lechat","year":"2022","journal-title":"Nat Sci Sleep"},{"issue":"3","key":"10.1016\/j.sleepx.2026.100188_bib10","first-page":"257","article-title":"The public health burden of obstructive sleep apnea","volume":"14","author":"Faria","year":"2021","journal-title":"Sleep Sci"},{"issue":"1","key":"10.1016\/j.sleepx.2026.100188_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jsmc.2019.10.002","article-title":"Insomnia and cognitive performance","volume":"15","author":"Brownlow","year":"2020","journal-title":"Sleep Med Clin"},{"key":"10.1016\/j.sleepx.2026.100188_bib12","series-title":"Bridgewater, NJ: sanofi-aventis U.S","year":"2022"},{"issue":"18","key":"10.1016\/j.sleepx.2026.100188_bib13","doi-asserted-by":"crossref","first-page":"9720","DOI":"10.3390\/ijerph18189720","article-title":"The association between use of benzodiazepine receptor agonists and the risk of obstructive sleep apnea: a nationwide population-based nested case-control study","volume":"18","author":"Hsu","year":"2021","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.sleepx.2026.100188_bib14","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3389\/fphar.2018.01513","article-title":"Benzodiazepines associated with acute respiratory failure in patients with obstructive sleep apnea","volume":"9","author":"Wang","year":"2018","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.sleepx.2026.100188_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"10.1016\/j.sleepx.2026.100188_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/pr.117.014381","article-title":"Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery","volume":"70","author":"Atkin","year":"2018","journal-title":"Pharmacol Rev"},{"issue":"10","key":"10.1016\/j.sleepx.2026.100188_bib17","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.5664\/jcsm.7370","article-title":"Use of sedative-hypnotics and mortality: a population-based retrospective cohort study","volume":"14","author":"Choi","year":"2018","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.sleepx.2026.100188_bib18","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/hex.12388","article-title":"People with insomnia: experiences with sedative hypnotics and risk perception","volume":"19","author":"Cheung","year":"2016","journal-title":"Health Expect"},{"key":"10.1016\/j.sleepx.2026.100188_bib19","series-title":"CPAP adherence: factors and perspectives","first-page":"195","article-title":"Overview of medication treatment for co-morbid insomnia and sleep apnea (COMISA)","author":"Lowe","year":"2022"},{"key":"10.1016\/j.sleepx.2026.100188_bib20","first-page":"2691","article-title":"Obstructive sleep apnea: management considerations in psychiatric patients","volume":"11","author":"Heck","year":"2015","journal-title":"Neuropsychiatric Dis Treat"},{"issue":"4","key":"10.1016\/j.sleepx.2026.100188_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/bcp.13153","article-title":"Impact of concomitant medications on obstructive sleep apnoea","volume":"83","author":"Jullian-Desayes","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.sleepx.2026.100188_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12853","article-title":"The effects of zolpidem in obstructive sleep apnea - an open-label pilot study","volume":"28","author":"Carberry","year":"2019","journal-title":"J Sleep Res"},{"issue":"1","key":"10.1016\/j.sleepx.2026.100188_bib23","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00149-2018","article-title":"Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial","volume":"52","author":"Carter","year":"2018","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.sleepx.2026.100188_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01344-2017","article-title":"Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem","volume":"50","author":"Carberry","year":"2017","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.sleepx.2026.100188_bib25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.5665\/sleep.5622","article-title":"Zopiclone increases the arousal threshold without impairing genioglossus activity in obstructive sleep apnea","volume":"39","author":"Carter","year":"2016","journal-title":"Sleep"},{"issue":"12","key":"10.1016\/j.sleepx.2026.100188_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1042\/CS20100588","article-title":"Eszopiclone increases the respiratory arousal threshold and lowers the apnoea\/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold","volume":"120","author":"Eckert","year":"2011","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.sleepx.2026.100188_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/atm.ATM_198_18","article-title":"The effect of nonbenzodiazepines sedative hypnotics on apnea-hypopnea index: a meta-analysis","volume":"14","author":"Nigam","year":"2019","journal-title":"Ann Thorac Med"},{"issue":"9","key":"10.1016\/j.sleepx.2026.100188_bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40266-024-01135-8","article-title":"Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials","volume":"41","author":"Gotfried","year":"2024","journal-title":"Drugs Aging"},{"key":"10.1016\/j.sleepx.2026.100188_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.sleep.2018.06.011","article-title":"Effects of zolpidem\/triazolam on cognitive performance 12 hours after acute administration","volume":"52","author":"Matsunaga","year":"2018","journal-title":"Sleep Med"},{"issue":"10","key":"10.1016\/j.sleepx.2026.100188_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa080","article-title":"Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial","volume":"43","author":"Neylan","year":"2020","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.sleepx.2026.100188_bib31","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/13803395.2014.928268","article-title":"The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis","volume":"36","author":"Stranks","year":"2014","journal-title":"J Clin Exp Neuropsychol"},{"issue":"3","key":"10.1016\/j.sleepx.2026.100188_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy258","article-title":"Effects of zolpidem and zaleplon on cognitive performance after emergent morning awakenings at Tmax: a randomized placebo-controlled trial","volume":"42","author":"Dinges","year":"2019","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.sleepx.2026.100188_bib33","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2125.2006.02705.x","article-title":"A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers","volume":"62","author":"Hindmarch","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.sleepx.2026.100188_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1037\/a0025237","article-title":"Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use","volume":"20","author":"Kleykamp","year":"2012","journal-title":"Exp Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.sleepx.2026.100188_bib35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1590\/1980-57642021dn15-030013","article-title":"Cognitive and balance dysfunctions due to the use of zolpidem in the elderly: a systematic review","volume":"15","author":"Tavares","year":"2021","journal-title":"Dement Neuropsychol"},{"issue":"3","key":"10.1016\/j.sleepx.2026.100188_bib36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/npr2.12262","article-title":"Residual effects of low dose of suvorexant, zolpidem, and ramelteon in healthy elderly subjects: a randomized double-blind study","volume":"42","author":"Uemura","year":"2022","journal-title":"Neuropsychopharmacol Rep"},{"issue":"5","key":"10.1016\/j.sleepx.2026.100188_bib37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.5664\/jcsm.8294","article-title":"Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening","volume":"16","author":"Murphy","year":"2020","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"10.1016\/j.sleepx.2026.100188_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/00325481.2020.1823724","article-title":"Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials","volume":"133","author":"Moline","year":"2021","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.sleepx.2026.100188_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13021","article-title":"Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: a randomized, double-blind, placebo-controlled, crossover study","volume":"29","author":"Cheng","year":"2020","journal-title":"J Sleep Res"},{"issue":"1","key":"10.1016\/j.sleepx.2026.100188_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5664\/jcsm.10788","article-title":"A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea","volume":"20","author":"Cheng","year":"2024","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleepx.2026.100188_bib41","article-title":"Respiratory safety of lemborexant in adult and elderly subjects with moderate-to-severe chronic obstructive pulmonary disease","author":"Cheng","year":"2024","journal-title":"J Sleep Res"},{"issue":"12","key":"10.1016\/j.sleepx.2026.100188_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18254","article-title":"Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial","volume":"2","author":"Rosenberg","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.sleepx.2026.100188_bib43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.sleep.2024.12.023","article-title":"Effect of lemborexant on sleep architecture in participants with insomnia disorder and mild obstructive sleep apnea","volume":"127","author":"Kushida","year":"2024","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleepx.2026.100188_bib44","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"issue":"4","key":"10.1016\/j.sleepx.2026.100188_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the insomnia severity index as an outcome measure for insomnia research","volume":"2","author":"Bastien","year":"2001","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.sleepx.2026.100188_bib46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2125.2000.00131.x","article-title":"Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteers","volume":"49","author":"Wesnes","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sleepx.2026.100188_bib47","article-title":"Residual effects of sleep medications are commonly reported and associated with impaired patient-reported outcomes among insomnia patients in the United States","volume":"2015","author":"Fitzgerald","year":"2015","journal-title":"Sleep Disord"},{"issue":"4","key":"10.1016\/j.sleepx.2026.100188_bib48","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/JCP.0000000000001562","article-title":"Acute cognitive effects of the dual orexin receptor antagonist lemborexant compared with suvorexant and zolpidem in recreational sedative users","volume":"42","author":"Landry","year":"2022","journal-title":"J Clin Psychopharmacol"}],"container-title":["Sleep Medicine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590142726000169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590142726000169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:45:13Z","timestamp":1781019913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590142726000169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":48,"alternative-id":["S2590142726000169"],"URL":"https:\/\/doi.org\/10.1016\/j.sleepx.2026.100188","relation":{},"ISSN":["2590-1427"],"issn-type":[{"value":"2590-1427","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of lemborexant on insomnia severity, morning alertness, and cognition in participants with insomnia disorder and mild obstructive sleep apnea","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleepx.2026.100188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100188"}}